8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)
Published . Updated .
Key takeaways
- 8-K - ANI PHARMACEUTICALS filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: ANIP
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - ANI PHARMACEUTICALS filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- ANIP Ani Pharmaceuticals-5.0% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+7.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+5.9% 19d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ANIP | +3.29% | +3.69% | base | after close | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | after close | after close | after close | after close |
| XBI | +5.09% | +4.40% | base | after close | after close | after close | after close |
| LLY | +3.64% | +3.08% | base | after close | after close | after close | after close |
| JNJ | +0.29% | -2.31% | base | after close | after close | after close | after close |
| PFE | +2.07% | +0.33% | base | after close | after close | after close | after close |
| MRK | +1.80% | -1.52% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001104659-26-123446 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Ite…
Source: sec-edgar
The price since 5 Nov 2026: Ani Pharmaceuticals (ANIP) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Ani Pharmaceuticals (ANIP) | three days earlier | +3.69% | final price |
| Ani Pharmaceuticals (ANIP) | five days earlier | +3.29% | final price |
| JNJ | three days earlier | -2.31% | final price |
| JNJ | five days earlier | +0.29% | final price |
| LLY | three days earlier | +3.08% | final price |
| LLY | five days earlier | +3.64% | final price |
| MRK | three days earlier | -1.52% | final price |
| MRK | five days earlier | +1.80% | final price |
| PFE | three days earlier | +0.33% | final price |
| PFE | five days earlier | +2.07% | final price |
| XBI | three days earlier | +4.40% | final price |
| XBI | five days earlier | +5.09% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 58 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 76 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)”
Companies mentioned with this story
- ANIP Ani Pharmaceuticals
Ani Pharmaceuticals (ANIP) is linked, with no stored direction, high confidence in the 5 Nov 2026 story “8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ANIP
How “8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)” reaches Ani Pharmaceuticals (ANIP)
Ani Pharmaceuticals (ANIP) is the company in “8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer),” the 5 Nov 2026 this story story.
The link for Ani Pharmaceuticals (ANIP) is this: SEC 8-K filing -> direct issuer disclosure -> ANIP
Dates and price levels for Ani Pharmaceuticals (ANIP)
ANIP traded between 69.90 and 79.33 across 20 sessions. The latest close on file is 71.66.
A simple score for Ani Pharmaceuticals (ANIP)
14 out of 100
“8-K - ANI PHARMACEUTICALS INC (0001023024) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.